MeSH tree: E05.337
Reports of commercial sexual exploitation of minors have skyrocketed 700% over the past decade in Orange County, especially non-trafficking exploitation, according to a new policy brief from UC Irvine researchers. Exploitation ...
8 hours ago
0
0
"DJ S-Low" leaned intently over a glowing digital controller, headphones on and head bobbing, as she mixed two tracks by New Order into one seamless transition.
Jan 29, 2026
0
1
A new randomized clinical trial finds that simple reminder emails substantially increase clinicians' use of a database that supports safe prescribing of opioids and other drugs, even though opioid prescribing patterns themselves ...
Dec 29, 2025
0
0
U.S. Food and Drug Administration (FDA) advisory committees play a key role in evaluating the efficacy and safety of new drugs. They include open public hearing sessions, whereby patients, clinicians, and advocates share ...
Nov 24, 2025
0
0
Expanding access to lifestyle medicine education opportunities—such as continuing medical education (CME) courses, professional certification, webinars, mentoring and peer-to-peer connections, and conference participation—can ...
Sep 23, 2025
0
0
Results from a new trial published in The Lancet Global Health show that a mobile application, Med Safety, improved the reporting of suspected adverse drug reactions (ADRs) by health care workers in Uganda.
Sep 18, 2025
0
0
Adverse drug reactions (ADRs) are a significant cause of hospital admissions and treatment discontinuation worldwide. Conventional approaches often fail to detect rare or delayed effects of medicinal products. In order to ...
Aug 6, 2025
0
0
Dr. Marty Makary had just finished his last surgery at Johns Hopkins when he stepped into one of the most powerful roles in American public health.
May 1, 2025
0
0
A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in the United States and a medical issue costing more than $500 billion annually.
Apr 3, 2025
0
25
Cases of secondary tumors have been reported as a possible adverse reaction to the treatment of certain blood cancers with CAR T-cells. A recent analysis of the cases reported to the Paul-Ehrlich-Institut highlights the challenges ...
Jan 24, 2025
0
0
